register

News & Trends - Biotechnology

New partnership to advance genomic research in Australasia

Health Industry Hub | July 3, 2024 |

Biotech News: The Australian Genome Research Facility (AGRF) has entered a strategic partnership with US-based Dovetail Genomics.

As Australia’s non-profit genomic sequencing service provider, AGRF powers genomics through a national network of services and expertise. This collaboration is aimed at bolstering genomic research and innovation across Australia and New Zealand, launching AGRF as the premier provider of Dovetail’s cutting-edge products and services in the Australasian market.

Under this partnership, AGRF will offer Dovetail’s comprehensive 3D genomic portfolio of proximity ligation-based products, including Dovetail Omni-C, Micro-C, and the new family of LinkPrep Technology based products, TopoLink, AssemblyLink, and VariLink Kits. By integrating Dovetail’s proprietary technologies, AGRF will provide localised, high-quality genomic services, transforming the way researchers study the 3D genome.

This alliance not only redefines the accessibility and application of advanced genomics across various sectors, including biomedical, agri-genomics, and clinical research, but it also significantly enhances and expands AGRF’s service offerings.

Dr Mathew Easterday, CEO of Dovetail Genomics, shared his enthusiasm for the new strategic partnership, stating, “Our collaboration with AGRF is not just a partnership; it’s a powerful union that combines Dovetail’s cutting-edge technological platforms with AGRF’s extensive and robust service network to unlock new research opportunities in Australasia.

“Together, we are committed to advancing genomic research and setting new benchmarks for what can be achieved in the realms of biomedical, agricultural, and clinical research.”

The collaboration aligns with global industry trends as Hi-C technologies gain traction across a plethora of genomic applications and disease states.

Dr Cath Moore, Chief Scientific Officer at AGRF, elaborated on the significance of the partnership, stating, “3D genomics is transformative for researchers utilising AGRF’s genomic services. Unlocking the spatial mysteries of DNA; how it folds and loops and how that impacts gene regulation, cell differentiation, genome stability, and disease mechanisms.

“Bringing this capability to AGRF, and so to the Australian research community, provides a comprehensive understanding of genome function beyond linear DNA sequences, transforming our knowledge of cellular biology and disease mechanisms.”

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the ONLY one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The exclusive leadership and influencer podcasts and vodcasts add huge value to our breaking news coverage. The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - Pharmaceuticals

Federal court dismisses Arrotex dispute against Health Minister

Federal court dismisses Arrotex dispute against Health Minister

Health Industry Hub | July 12, 2024 |

Pharma News: The Federal Court has ruled against Arrotex Pharmaceuticals in their bid to challenge the Minister for Health and […]

More


News & Trends - Pharmaceuticals

Largest diabetes study reveals major benefits of dual therapy with SGLT2 inhibitors and GLP1 receptor agonists

Largest diabetes study reveals major benefits of SGLT2 inhibitors and GLP1 receptor agonists dual therapy

Health Industry Hub | July 12, 2024 |

Pharma News: Combined use of sodium glucose co-transporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP1-RAs) is likely to […]

More


News & Trends - Pharmaceuticals

Queensland opens first regional CAR T-cell treatment centre

Queensland launches first regional CAR T-cell treatment centre

Health Industry Hub | July 12, 2024 |

Pharma News: Gilead Sciences and Lymphoma Australia have welcomed the opening of Australia’s first regional CAR T-cell treatment centre at […]

More


News & Trends - Pharmaceuticals

Government inaction leaves essential medicine shortages unresolved

Government inaction leaves essential medicine shortages unresolved

Health Industry Hub | July 12, 2024 |

Pharma News: Over the past 12 months, at least six essential medications and products have been withdrawn from the Australian […]

More


This content is copyright protected. Please subscribe to gain access.